Concepedia
Statistics
Publications
17
Citations
1K
H-Index
14
Active since
1999
Affiliations
Tokushima University(Current)
Chugai Pharma (United States)
Tokushima University Hospital
The University of Tokyo
Tokushima Red Cross Hospital
Shigeto Kawai is an author at Tokushima University specializing in oncology, immunology, and medicine.
Publications per year
1999–2025
Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family
Masahiko Mihara, Keiko Kasutani, Makoto Okazaki et al. · International Immunopharmacology · 2005 · 323 citations
Life Sciences, Immunology, Pharmacology +14
Molecular Cloning and Characterization of a Surface Antigen Preferentially Overexpressed on Multiple Myeloma Cells
Toshihiko Ohtomo, Yasuhiro Sugamata, Yasuko Ozaki et al. · Biochemical and Biophysical Research Communications · 1999 · 201 citations
Life Sciences, Cell Biology, Molecular Biology +15
Identification of ROBO1 as a Novel Hepatocellular Carcinoma Antigen and a Potential Therapeutic and Diagnostic Target
Hirotaka Ito, S. Funahashi, Naoko Yamauchi et al. · Clinical Cancer Research · 2006 · 101 citations
Medicine, Molecular Biology, Oncology +17
Interferon‐α enhances CD317 expression and the antitumor activity of anti‐CD317 monoclonal antibody in renal cell carcinoma xenograft models
Shigeto Kawai, Yumiko Azuma, Etsuko Fujii et al. · Cancer Science · 2008 · 41 citations · Full text
Medicine, Immunology, Oncology +17
The humanized anti-HM1.24 antibody effectively kills multiple myeloma cells by human effector cell-mediated cytotoxicity
Koichiro Ono, Toshihiko Ohtomo, Kenji Yoshida et al. · Molecular Immunology · 1999 · 40 citations
Medicine, Immunology, Oncology +8
1–5 of 17